补充因子H:在癌症免疫治疗中,一种新的先天性免疫检查点
Ruchi Saxena1, Elizabeth B Gottlin2, Michael J Campa2
1Department of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, United States.
Frontiers in cell and developmental biology
|February 23, 2024
概括
癌症对免疫系统的逃避是一个重大挑战. 补充因子H (CFH) 充当天生的免疫检查点,通过抑制免疫反应和创造免疫抑制瘤微环境来促进瘤生长.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 补充系统生物学 补充系统生物学
背景情况:
- 癌细胞的消灭依赖于免疫监测.
- 瘤发展出逃避机制,阻碍免疫监测并促进进展.
- 补充因子H (CFH) 被认为是癌症中关键的先天免疫检查点.
研究的目的:
- 审查CFH作为癌症的先天性免疫检查点的作用.
- 探索分子机制,免疫细胞相互作用和CFH在癌症中的临床影响.
- 讨论在癌症免疫治疗中针对CFH的治疗策略.
主要方法:
- 在癌症免疫学中对CFH现有研究的文献综述.
- 通过CFH调解的分子通路和免疫细胞相互作用的分析.
- 评估针对CFH的临床数据和治疗潜力.
主要成果:
- CFH积极抑制对瘤的免疫反应.
- CFH促进免疫逃避,并建立一个免疫抑制瘤微环境.
- CFH在瘤进展和抵抗免疫攻击方面发挥着重要作用.
结论:
- CFH是一个关键的先天免疫检查点,可以促进癌症的进展.
- 向CFH为新型癌症免疫疗法提供了一个有希望的途径.
- 需要进一步的研究来克服挑战并优化针对CFH的治疗策略.
更多相关视频
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Cytotoxic T Cells-mediated Immune Response
910
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
910


